Top-News
Pharmazeutika Norwegen

Photocure Aktie

Aktie
WKN:  931150 ISIN:  NO0010000045 US-Symbol:  PHCUF
4,34 €
-0,67 €
-13,37%
02.12.24
Handeln Depot/Watchlist
Aktienanzahl *
27,11 Mio.
Marktkapitalisierung *
116,71 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.12.2023

Photocure News

09.08.22 - PR Newswire
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial PR Newswire
09.08.22 - PR Newswire
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial PR Newswire
11.05.22 - PR Newswire
Photocure ASA: Results for the first quarter of 2022
Photocure ASA: Results for the first quarter of 2022 PR Newswire
11.03.22 - PR Newswire
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-​World Evidence Study in China PR Newswire
11.03.22 - PR Newswire
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-​World Evidence Study in China PR Newswire
23.06.21 - PR Newswire
New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in Non-Muscle Invasive Bladder Cancer
New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in Non-​Muscle Invasive Bladder Cancer PR Newswire
23.06.21 - PR Newswire
New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in Non-Muscle Invasive Bladder Cancer
New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in Non-​Muscle Invasive Bladder Cancer PR Newswire
27.05.21 - PR Newswire
Photocure to Present at Two Upcoming Investor Conferences in June
Photocure to Present at Two Upcoming Investor Conferences in June PR Newswire
27.05.21 - PR Newswire
Photocure to Present at Two Upcoming Investor Conferences in June
Photocure to Present at Two Upcoming Investor Conferences in June PR Newswire
19.05.21 - PR Newswire
Photocure ASA: Results for the first quarter of 2021
Photocure ASA: Results for the first quarter of 2021 PR Newswire
19.05.21 - PR Newswire
Photocure ASA: Results for the first quarter of 2021
Photocure ASA: Results for the first quarter of 2021 PR Newswire
18.05.21 - PR Newswire
Photocure announces Hexvix regulatory filing accepted for review in Chile with Fast Track designation
Photocure announces Hexvix regulatory filing accepted for review in Chile with Fast Track designation PR Newswire
18.05.21 - PR Newswire
Photocure announces Hexvix regulatory filing accepted for review in Chile with Fast Track designation
Photocure announces Hexvix regulatory filing accepted for review in Chile with Fast Track designation PR Newswire
30.04.21 - PR Newswire
Photocure publishes its 2020 ESG Report
Photocure publishes its 2020 ESG Report PR Newswire
03.03.21 - PR Newswire
Photocure ASA: Results for the fourth quarter of 2020
Photocure ASA: Results for the fourth quarter of 2020 PR Newswire
26.01.21 - PR Newswire
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan PR Newswire
26.01.21 - PR Newswire
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Mainland China and Taiwan Agreement Expands Photocure's Hexvix®/Cysview® Franchise Footprint to over 30 ...
07.12.20 - PR Newswire
New abstracts on the use of Blue Light Cystoscopy with Cysview presented at SUO
New abstracts on the use of Blue Light Cystoscopy with Cysview presented at SUO PR Newswire
10.11.20 - PR Newswire
Photocure ASA: Results for the third quarter of 2020
Photocure ASA: Results for the third quarter of 2020 PR Newswire
10.11.20 - PR Newswire
Photocure ASA: Results for the third quarter of 2020
Photocure ASA: Results for the third quarter of 2020 PR Newswire

Newssuche

Videos

newspaper
08:20 Uhr
Technical Trading: Baumwolle Long, weil...
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »